1. Home
  2. LUMO
  3. LUMO News

Latest Lumos Pharma Inc. (LUMO) News on November 15, 2024

Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024
LUMO

GlobeNewswire

15 days ago

Lumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024

Discover Smart Share Global Among 2 Other Prominent US Penny Stocks
LUMO

Simply Wall St.

20 days ago

Discover Smart Share Global Among 2 Other Prominent US Penny Stocks

Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR)
LUMO

GlobeNewswire

23 days ago

Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR)

Lumos Pharma Inc (LUMO) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Prudence
LUMO

GuruFocus.com

a month ago

Lumos Pharma Inc (LUMO) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Prudence

Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024
LUMO

GlobeNewswire

2 months ago

Lumos Pharma Announces Abstract Accepted for Oral Presentation at the 13th Biennial Scientific Meeting of the Asia Pacific Pediatric Endocrine Society, APPES 2024

Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024
LUMO

GlobeNewswire

2 months ago

Lumos Pharma Announces Abstract Accepted for Presentation at September Medical Meeting, SLEP 2024

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
LUMO

GlobeNewswire

3 months ago

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Lumos Pharma Second Quarter 2024 Earnings: Beats Expectations
LUMO

Simply Wall St.

3 months ago

Lumos Pharma Second Quarter 2024 Earnings: Beats Expectations

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
LUMO

GlobeNewswire

3 months ago

Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update

Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024
LUMO

GlobeNewswire

4 months ago

Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024

Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
LUMO

GlobeNewswire

5 months ago

Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024

Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024
LUMO

GlobeNewswire

6 months ago

Lumos Pharma Announces Abstracts Accepted for Presentation at ENDO 2024

LUMO

GuruFocus.com

6 months ago

Lumos Pharma Inc (LUMO) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial ...

Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
LUMO

GlobeNewswire

6 months ago

Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results

Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024
LUMO

GlobeNewswire

6 months ago

Lumos Pharma to Report First Quarter 2024 Financial Results and Provide Clinical Update on May 15, 2024

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
LUMO

GlobeNewswire

7 months ago

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings

Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042
LUMO

GlobeNewswire

8 months ago

Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042

Lumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
LUMO

Simply Wall St.

8 months ago

Lumos Pharma Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript
LUMO

Insider Monkey

8 months ago

Lumos Pharma, Inc. (NASDAQ:LUMO) Q4 2023 Earnings Call Transcript

Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update
LUMO

GlobeNewswire

8 months ago

Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update

Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
LUMO

GlobeNewswire

9 months ago

Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024

Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference
LUMO

GlobeNewswire

9 months ago

Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference

Is Lumos Pharma (NASDAQ:LUMO) In A Good Position To Invest In Growth?
LUMO

Simply Wall St.

9 months ago

Is Lumos Pharma (NASDAQ:LUMO) In A Good Position To Invest In Growth?

With the S&P 500 at a record high, strategists warn against a valuation 'trap'
LUMO

Yahoo Finance

10 months ago

With the S&P 500 at a record high, strategists warn against a valuation 'trap'

CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS
LUMO

PR Newswire

10 months ago

CFSB BANCORP, INC. ANNOUNCES FISCAL SECOND QUARTER AND YEAR-TO-DATE 2024 FINANCIAL RESULTS

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment
LUMO

NewMediaWire

10 months ago

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment

After losing 41% in the past year, Neuronetics, Inc. (NASDAQ:STIM) institutional owners must be relieved by the recent gain
LUMO

Simply Wall St.

10 months ago

After losing 41% in the past year, Neuronetics, Inc. (NASDAQ:STIM) institutional owners must be relieved by the recent gain

American Resources' (AREC) Arm Executes MOU With Duesenfeld
LUMO

Zacks

10 months ago

American Resources' (AREC) Arm Executes MOU With Duesenfeld

Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer
LUMO

GlobeNewswire

10 months ago

Lumos Pharma Promotes Pisit “Duke” Pitukcheewanont, MD to Chief Medical Officer

BIT Mining Limited Agrees to Sell its Mining Pool Business
LUMO

PR Newswire

a year ago

BIT Mining Limited Agrees to Sell its Mining Pool Business

Broadwind (NASDAQ:BWEN) swells 10% this week, taking five-year gains to 118%
LUMO

Simply Wall St.

a year ago

Broadwind (NASDAQ:BWEN) swells 10% this week, taking five-year gains to 118%

Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Q4 2023 Earnings Call Transcript
LUMO

Insider Monkey

a year ago

Innovative Solutions and Support, Inc. (NASDAQ:ISSC) Q4 2023 Earnings Call Transcript

7 Micro-Cap Stocks for Risk-Tolerant Investors to Buy in 2024
LUMO

InvestorPlace

a year ago

7 Micro-Cap Stocks for Risk-Tolerant Investors to Buy in 2024

ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock
LUMO

PR Newswire

a year ago

ACRES Commercial Realty Corp. Declares Quarterly Cash Dividends for its Preferred Stock

LUMO

PR Newswire

a year ago

Energy Services of America Announces Financial Results for the Fiscal Year Ended September 30, 2023

Loop Media, Inc. (PNK:LPTV) Q4 2023 Earnings Call Transcript
LUMO

Insider Monkey

a year ago

Loop Media, Inc. (PNK:LPTV) Q4 2023 Earnings Call Transcript

LUMO

Thomson Reuters StreetEvents

a year ago

Q1 2024 Zedge Inc Earnings Call

Zedge Announces First Quarter Fiscal 2024 Results
LUMO

ACCESSWIRE

a year ago

Zedge Announces First Quarter Fiscal 2024 Results

Valens Semiconductor Appoints Guy Nathanzon as Chief Financial Officer
LUMO

PR Newswire

a year ago

Valens Semiconductor Appoints Guy Nathanzon as Chief Financial Officer

LUMO

PR Newswire

a year ago

So-Young Enters into Strategic Partnership with Healtech to Further Expand Supply Chain Business

ACRES Commercial Realty Corp. Reauthorizes an Additional $10 Million Share Repurchase Program
LUMO

PR Newswire

a year ago

ACRES Commercial Realty Corp. Reauthorizes an Additional $10 Million Share Repurchase Program

TrueBlue's PeopleReady Earns Dual Awards for Innovative JobStack App
LUMO

PR Newswire

a year ago

TrueBlue's PeopleReady Earns Dual Awards for Innovative JobStack App

So-Young International Inc.'s (NASDAQ:SY) top owners are retail investors with 41% stake, while 34% is held by private equity firms
LUMO

Simply Wall St.

a year ago

So-Young International Inc.'s (NASDAQ:SY) top owners are retail investors with 41% stake, while 34% is held by private equity firms

Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency
LUMO

GlobeNewswire

a year ago

Lumos Pharma to Host Virtual Key Opinion Leader Webinar to Discuss Phase 2 OraGrowtH Trial Data and Treatment Potential of Oral LUM-201 for Pediatric Growth Hormone Deficiency

Stardust Power Inc. To Go Public Through Business Combination with Nasdaq Listed Global Partner Acquisition Corporation II
LUMO

Business Wire

a year ago

Stardust Power Inc. To Go Public Through Business Combination with Nasdaq Listed Global Partner Acquisition Corporation II

Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November
LUMO

GlobeNewswire

a year ago

Lumos Pharma Announces Participation in the Piper Sandler 35th Annual Healthcare Conference in November

LUMO

PR Newswire

a year ago

ENERGY SERVICES OF AMERICA ANNOUNCES ANNUAL DIVIDEND

KVH Crew Wellbeing Solutions Honored with 2023 CAREER4SEA Europort Award
LUMO

GlobeNewswire

a year ago

KVH Crew Wellbeing Solutions Honored with 2023 CAREER4SEA Europort Award

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
LUMO

GlobeNewswire

a year ago

Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives

Mammoth Energy Services, Inc. (NASDAQ:TUSK) Q3 2023 Earnings Call Transcript
LUMO

Insider Monkey

a year ago

Mammoth Energy Services, Inc. (NASDAQ:TUSK) Q3 2023 Earnings Call Transcript

Desktop Metal, Inc. (NYSE:DM) Q3 2023 Earnings Call Transcript
LUMO

Insider Monkey

a year ago

Desktop Metal, Inc. (NYSE:DM) Q3 2023 Earnings Call Transcript

Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates
LUMO

GlobeNewswire

a year ago

Lumos Pharma Reports Third Quarter 2023 Financial Results and Clinical Development Updates

LUMO

Associated Press Finance

a year ago

National CineMedia: Q3 Earnings Snapshot

Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints
LUMO

GlobeNewswire

a year ago

Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints

Share on Social Networks: